This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Health Care Notification Network
New Service Replaces Paper-based Product Safety Alerts With E-mails
"It's slow, it's expensive -- often with weeks of delay between the time a notice is required and (when) it actually reaches the physician's hands," Dickey said, referring to the current paper-based notification system. "It's ineffective -- literally stacks of mail come into a physician's office, and it's not uncommon for an alert to be mistaken for marketing and simply tossed away."
Indeed, in a 2006 guidance statement, the FDA specifically addressed the potential benefits of using electronic means to convey voluntary recall communications about FDA-regulated products and important drug safety information, acknowledging the potential pitfalls of using paper notices.
"Many are now concerned that these important drug information communications sent to physicians and other health care providers are not reaching the intended audience in a timely manner or at all," the FDA statement reads. "Letters to health care providers often are screened by one or more 'gatekeepers' and may not reach the intended recipients -- the providers who need the drug information for treating patients."
Mail-based System Heightens Liability Risk
The physician liability issue is key, according to Fotsch, and is the chief driver behind the widespread support the HCNN has achieved among medical liability carriers. To date, more than three dozen medical malpractice carriers have announced their support for the network.
Also signing on to the venture are some 20 health insurers and health care organizations, nearly a dozen medical societies and physician and trade organizations, and various other health care entities.
Janet Woodcock, M.D., acting director of the FDA's Center for Drug Evaluation and Research, saluted the HCNN "for stepping up to the plate and for providing this service."
"FDA fully supports the transition to an interactive, electronic information environment for safety information both for drugs and devices and for biologicals," Woodcock said during the launch event. "We feel this way, doctors and other prescribers, health care professionals, won't be hearing of problems first from the media or from concerned patients who come into their office. So they will not be blind-sided; they will have the emerging information as soon as it's available."
That same timeliness factor is prompting negotiations between the HCNN and the CDC regarding the possibility of using the network to send alerts about national public health emergencies, such as those pertaining to a major infectious disease outbreak or bioterrorism event.
Information Targeted by Specialty
Other benefits of the new service include the clinician's ability to add an office manager or other staff member to the list of designated recipients and a feature that makes it easy for clinicians to send patients appropriate information from HCNN alerts using the clinicians' pre-existing practice e-mail systems.
FDA Finds Yet More ED Agents Unsafe
'Blue Steel,' 'Hero' Join Long List of Hazardous 'Supplements' for Men
(4/2/2008)
Additional Resource
MedWatch: the FDA Safety Information and Adverse Event Reporting Program
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Study: PPI Does Not Routinely Improve Asthma Control
Recalled Oral Contraceptives Pose Pregnancy Risk
CDC to Fund 2D Vaccine Barcoding Pilot
2012 Immunization Schedules Reflect Multiple Changes
Study: Cognitive Decline Detected in Middle-aged Adults
CDC Toolkit Can Help Clinicians Fight Norovirus Infection
Patient-Centered Care Linked to Lower Mortality
Study: Inappropriate Cancer Screenings Continue
Novartis Manufacturing Plant Closes After Drug Mix-ups
FDA Announces Classwide REMS for TIRF Medications
New Infants' Acetaminophen Products Hit Store Shelves
Avoid Environmental Factors Linked to Breast Cancer
Risk for Thrombosis Prompts REMS for Rivaroxaban
Common Drugs Implicated in Most Emergency Hospitalizations
CDC Launches Campaign for Child Medication Safety
HHS Blocks Expanded OTC Access to Plan B
Push Is On to Vaccinate Pregnant, Postpartum Women
FDA Committee Votes to Broaden PCV13 Indication
AAFP Foundation Program Aims to Fight Chronic Disease
NIAAA Alcohol Screening Guide Targets Teens
Walgreens, AAFP Launch Flu Vaccine Pilot in Five States
Helping Patients Quit Smoking Starts With a Question
Trilipix Efficacy in Question, Says FDA
USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening
AAFP Endorses ACP Guideline on ED
ACIP Recommends Expanded HPV, Hepatitis B Vaccination
Bacterial Contamination Spurs Nasal Spray Recall
CDC Renews Call for PCV13 Vaccination
USPSTF Recommends Against PSA Screening
AAFP Supports HHS' Million Hearts Initiative
FDA Phases Out Primatene Mist Inhalers
AHRQ Guides Explain Benefits, Risks of GERD Treatments
Office Champions Project Nets Smoking Cessation Gains
Multiple Lots of Oral Contraceptives Recalled
New Vaccine Review Finds Few Adverse Events
HPV Vaccination Rates Still Lag, Says CDC
Renal Injury Prompts Reclast Label Changes
High-dose Citalopram Linked to Abnormal Heart Rhythms
AHRQ Sleep Apnea Guides Review Diagnosis, Management
Board Chair Spotlights Breadth of Family Medicine Training
USPSTF Softens Stance on Bladder Cancer Screening
HHS Expands Coverage for Women's Preventive Services
Teledermatology Project Aids Underserved Patients
